Gyre Therapeutics GYRE
NASDAQ GYRE
$7.11 +0.11 (+1.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Gyre Therapeutics (GYRE) reported Depreciation & Amortization (CF) of $1.48 million for Q2 2026, up 47.0% from $1.01 million a year earlier and up 120.7% from the prior quarter.

Analysis

Gyre Therapeutics (GYRE) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Gyre Therapeutics' Depreciation & Amortization (CF) came in at $3.09 million, up 26.2% year-over-year; for FY2025, it was $2.48 million, up 60.2% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of 78.2% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $1.55 million in FY2024 (+44.2%), $1.07 million in FY2023 (-1.2%), $1.09 million in FY2022 (+274.8%) and $290,000 in FY2021 (+110.1%).
  • The Q2 2026 figure ranks as the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2010.
  • Year over year, Depreciation & Amortization (CF) has now increased in each of the last three quarters, with growth averaging 79.5% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q4 2022 (growth of 653.9%); the low point was Q4 2023 (a decline of 65.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $672,000 (Q1 2026), $656,000 (Q4 2025) and $281,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 Gyre Therapeutics 753.90 Mn 556.61 Mn 26.90 Mn 1.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.48 Mn
Mar 31, 2026 672,000.00
Dec 31, 2025 656,000.00
Sep 30, 2025 281,000.00
Jun 30, 2025 1.01 Mn
Mar 31, 2025 535,000.00
Dec 31, 2024 461,000.00
Sep 30, 2024 445,000.00
Jun 30, 2024 228,000.00
Mar 31, 2024 415,000.00
Dec 31, 2023 298,000.00
Sep 30, 2023 192,000.00
Jun 30, 2023 308,000.00
Mar 31, 2023 276,000.00
Dec 31, 2022 867,000.00
Sep 30, 2022 40,000.00
Jun 30, 2022 67,000.00
Mar 31, 2022 113,000.00
Dec 31, 2021 115,000.00
Sep 30, 2021 85,000.00
API Access

Gyre Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=GYRE&period=max&api_key=YOUR_API_KEY